Rabeprazole

Rabeprazole

SCHEMBL4751232

COCCCOc1ccnc(C[S@+]([O-])c2nc3ccccc3[nH]2)c1C.[KH]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.60
▸ CYP2C9 P11712 4/20 0.60
▸ WDR5 P61964 4/20 0.60
▸ LMNA P02545 4/20 0.60
▸ ENGASE Q8NFI3 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ MAPT P10636 3/20 0.60
▸ DDAH1 O94760 2/20 0.60
▸ ADORA3 P0DMS8 2/20 0.60
▸ HPGD P15428 2/20 0.60
▸ TBXA2R P21731 2/20 0.60
▸ NPY1R P25929 2/20 0.60
▸ ADORA1 P30542 2/20 0.60
▸ OPRM1 P35372 2/20 0.60
▸ HTR3A P46098 2/20 0.60
▸ FASN P49327 2/20 0.60
▸ SARM1 Q6SZW1 2/20 0.60
▸ ABCG2 Q9UNQ0 2/20 0.60
▸ HTR1A P08908 1/20 0.60
▸ IDE P14735 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rabeprazole SCHEMBL4751230 1.00 KMT2A (0.60) KMT2ACYP2C9WDR5LMNAENGASE
Rabeprazole SCHEMBL29360086 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Rabeprazole SCHEMBL29374701 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Rabeprazole SCHEMBL29833678 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Dexrabeprazole SCHEMBL30945135 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Dexrabeprazole SCHEMBL30019061 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Dexrabeprazole SCHEMBL4946138 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Rabeprazole SCHEMBL23337 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Rabeprazole SCHEMBL23336 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE
Dexrabeprazole SCHEMBL29493315 0.99 KMT2A (0.61) KMT2ACYP2C9WDR5LMNAENGASE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113425717-B Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof 成都欧林生物科技股份有限公司 2023-06-16 — — CN disclosed
CN-113425717-A Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof 成都欧林生物科技股份有限公司 2021-09-24 — — CN disclosed
WO-2008129517-A2 A STABILIZED DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF RABEPRAZOLE RANBAXY LABORATORIES LIMITED (IN) 2008-10-30 — — WO disclosed
EP-1605919-A1 STABLE PHARMACEUTICAL COMPOSITION OF RABEPRAZOLE AND PROCESSES FOR THEIR PREPARATION RANBAXY LABORATORIES, LTD. (IN) 2005-12-21 — — EP disclosed
WO-2004075881-A1 STABLE PHARMACEUTICAL COMPOSITION OF RABEPRAZOLE AND PROCESSES FOR THEIR PREPARATION RANBAXY LABORATORIES LIMITED (IN) 2004-09-10 — — WO disclosed
Send feedback